These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 16974207

  • 21. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD, Bodkin JA.
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [Abstract] [Full Text] [Related]

  • 22. Tricyclic-induced orthostatic hypotension. Significant difference in depressed and non-depressed states.
    Constantino EA, Roose SP, Woodring S.
    Pharmacopsychiatry; 1993 Jul; 26(4):125-7. PubMed ID: 8234451
    [No Abstract] [Full Text] [Related]

  • 23. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A, Fouilloux C, Ortiz S.
    Proc West Pharmacol Soc; 2002 Jul; 45():154-5. PubMed ID: 12434564
    [No Abstract] [Full Text] [Related]

  • 24. [Irreversible, non-selective monoamine oxidase inhibitors].
    Castberg I, Spigset O.
    Tidsskr Nor Laegeforen; 2009 Apr 16; 129(8):746-8. PubMed ID: 19373300
    [Abstract] [Full Text] [Related]

  • 25. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.
    van den Broek WW, Birkenhäger TK, Mulder PG, Bruijn JA, Moleman P.
    Psychopharmacology (Berl); 2004 Oct 16; 175(4):481-6. PubMed ID: 15243735
    [Abstract] [Full Text] [Related]

  • 26. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS, Lerfald SC, Bennett B, Laux D, Devereaux E, Kayser A, Corcella J, Albright D.
    Psychopharmacol Bull; 1991 Oct 16; 27(1):31-9. PubMed ID: 1862204
    [Abstract] [Full Text] [Related]

  • 27. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL, Sunderland T, Cohen RM.
    Psychiatr Clin North Am; 1984 Sep 16; 7(3):549-62. PubMed ID: 6384960
    [Abstract] [Full Text] [Related]

  • 28. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN, Brown BJ.
    Ann Pharmacother; 2006 Mar 16; 40(3):567-70. PubMed ID: 16478812
    [Abstract] [Full Text] [Related]

  • 29. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
    von Oefele K, Grohmann R, Hippius H, Rüther E.
    Nervenarzt; 1988 Feb 16; 59(2):118-23. PubMed ID: 3362260
    [No Abstract] [Full Text] [Related]

  • 30. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
    Nolen WA, Haffmans PM, Bouvy PF, Duivenvoorden HJ.
    J Affect Disord; 1993 Jul 16; 28(3):189-97. PubMed ID: 8408980
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
    Robinson DS, Nies A, Corcella J, Cooper TB, Spencer C, Keefover R.
    J Clin Psychiatry; 1982 May 16; 43(5 Pt 2):8-15. PubMed ID: 7042699
    [Abstract] [Full Text] [Related]

  • 32. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.
    Tijdschr Psychiatr; 2006 May 16; 48(4):271-81. PubMed ID: 16955991
    [Abstract] [Full Text] [Related]

  • 33. Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study.
    Cappiello A, McDougle CJ, Malison RT, Heninger GR, Price LH.
    Biol Psychiatry; 1995 Dec 01; 38(11):765-7. PubMed ID: 8580232
    [No Abstract] [Full Text] [Related]

  • 34. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA.
    Ned Tijdschr Geneeskd; 2003 Oct 04; 147(40):1940-3. PubMed ID: 14574774
    [Abstract] [Full Text] [Related]

  • 35. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP, Herbstein J, Damlouji N.
    J Clin Psychiatry; 1985 Jun 04; 46(6):206-9. PubMed ID: 3997787
    [Abstract] [Full Text] [Related]

  • 36. Serum zinc level in depressed patients during zinc supplementation of imipramine treatment.
    Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, Zieba A, Pilc A, Popik P, Nowak G.
    J Affect Disord; 2010 Nov 04; 126(3):447-52. PubMed ID: 20493532
    [Abstract] [Full Text] [Related]

  • 37. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
    Hashimoto K.
    J Clin Psychopharmacol; 2009 Aug 04; 29(4):411-2; author reply 412. PubMed ID: 19593196
    [No Abstract] [Full Text] [Related]

  • 38. Orthostatic side effects of clomipramine and moclobemide during treatment for depression.
    Stage KB, Danish University Antidepressant Group.
    Nord J Psychiatry; 2005 Aug 04; 59(4):298-301. PubMed ID: 16195134
    [Abstract] [Full Text] [Related]

  • 39. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P, Shu L, Xu X, Wang CY, Lee MS, Liu CY, Hong JP, Ruschel S, Raskin J, Colman SA, Harrison GA.
    Psychiatry Clin Neurosci; 2007 Jun 04; 61(3):295-307. PubMed ID: 17472599
    [Abstract] [Full Text] [Related]

  • 40. How to assess the onset of antidepressant effect: comparison of global ratings and findings based on depression scales.
    Möller HJ, Müller H, Volz HP.
    Pharmacopsychiatry; 1996 Mar 04; 29(2):57-62. PubMed ID: 8741022
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.